CAH - Cardinal Health, Inc.
(NaN%)
SNP 500
Hold
Moderate Growth and Improving
45%
based on last 5 year data.
Income Statement is MODERATE
Revenue Growth is 6.79%
Operating Income Growth is 185.49%
Net Income Growth is 355.87%
Earnings Per Share (EPS) Growth is 379.82%
Net Margin is 0.57%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 0.95
Debt Ratio is 0.98
Current Debt to Net Income Ratio is 2.26
Total Debt to Total Assets Ratio is 0.12
Cash Flow is MODERATE
Cash from Operations Growth is -52.61%
Capital Expenditure is High
Net Increase in Cash is Negative
Long Term Score Trend is POSITIVE
Investment Risk is Low
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Cardinal Health, Inc. (CAH) - https://www.cardinalhealth.com/
cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.Exchange - NEW YORK STOCK EXCHANGE INC.
Industry - Drugs and Druggists' Sundries Merchant Wholesalers
Sector - Wholesale Trade
CEO - Michael Kaufmann
Employees - 30,935
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2024 and future.
Know the Stock © 2024 and future.